CC - The Chemours Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
6,794,000
6,794,000
6,345,000
4,969,000
5,526,000
Cost of Revenue
5,178,000
5,178,000
4,964,000
3,902,000
4,463,000
Gross Profit
1,616,000
1,616,000
1,381,000
1,067,000
1,063,000
Operating Expenses
Research Development
118,000
118,000
107,000
93,000
80,000
Selling General and Administrative
710,000
710,000
592,000
527,000
548,000
Total Operating Expenses
830,000
828,000
699,000
620,000
628,000
Operating Income or Loss
786,000
788,000
682,000
447,000
435,000
Interest Expense
163,000
163,000
185,000
210,000
208,000
Total Other Income/Expenses Net
118,000
116,000
179,000
-58,000
-351,000
Income Before Tax
741,000
741,000
676,000
179,000
-124,000
Income Tax Expense
163,000
163,000
68,000
-40,000
-72,000
Income from Continuing Operations
578,000
578,000
608,000
219,000
-52,000
Net Income
578,000
578,000
608,000
219,000
-52,000
Net Income available to common shareholders
578,000
578,000
608,000
219,000
-52,000
Basic EPS
-
3.72
3.69
1.33
-0.32
Diluted EPS
-
3.65
3.60
1.32
-0.32
Basic Average Shares
-
155,359
164,944
164,682
164,817
Diluted Average Shares
-
158,303
168,698
166,347
164,817
EBITDA
-
1,195,000
1,178,000
709,000
395,000